Neximmune Company Top Insiders

Neximmune Management Team Effectiveness

The company has return on total asset (ROA) of (0.6971) % which means that it has lost $0.6971 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9648) %, meaning that it created substantial loss on money invested by shareholders. Neximmune's management efficiency ratios could be used to measure how well Neximmune manages its routine affairs as well as how well it operates its assets and liabilities. Neximmune secures 17.0 % of its outstanding shares held by insiders and 11.17 % owned by institutional investors. Some institutional investors establish a significant position in pink sheets such as Neximmune in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Neximmune, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Neximmune Workforce Comparison

Neximmune Insider Trading

Neximmune Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Neximmune often depends on how effective the management is. Neximmune management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neximmune management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neximmune management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.